ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,001 | -22.0% | 2,149 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $16,676 | -87.0% | 2,149 | -75.3% | 0.00% | -50.0% |
| Q4 2021 | $127,993 | -28.4% | 8,707 | +1.9% | 0.00% | -33.3% |
| Q3 2021 | $178,697 | +38.5% | 8,546 | +17.2% | 0.00% | +50.0% |
| Q2 2021 | $128,995 | -20.3% | 7,292 | +10.4% | 0.00% | 0.0% |
| Q1 2021 | $161,798 | -27.6% | 6,604 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $223,545 | +108.0% | 6,604 | +107.2% | 0.00% | +50.0% |
| Q2 2020 | $107,498 | – | 3,187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |